ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,150 | -79.6% | 114,949 | -21.0% | 0.00% | – |
| Q2 2023 | $74,196 | +6.6% | 145,482 | +31.7% | 0.00% | – |
| Q1 2023 | $69,591 | +6.1% | 110,461 | +9.3% | 0.00% | – |
| Q4 2022 | $65,607 | -56.3% | 101,075 | +14.6% | 0.00% | – |
| Q3 2022 | $150,000 | +127.3% | 88,234 | +67.0% | 0.00% | – |
| Q2 2022 | $66,000 | -40.5% | 52,829 | -69.0% | 0.00% | – |
| Q1 2022 | $111,000 | -67.8% | 170,650 | -46.2% | 0.00% | – |
| Q4 2021 | $345,000 | +124.0% | 317,048 | +273.5% | 0.00% | – |
| Q3 2021 | $154,000 | -63.6% | 84,883 | -47.0% | 0.00% | – |
| Q2 2021 | $423,000 | -38.7% | 160,195 | -16.5% | 0.00% | – |
| Q1 2021 | $690,000 | -15.1% | 191,790 | -40.5% | 0.00% | – |
| Q4 2020 | $813,000 | +13.7% | 322,413 | +13.7% | 0.00% | – |
| Q3 2020 | $715,000 | -14.8% | 283,640 | +10.9% | 0.00% | – |
| Q2 2020 | $839,000 | +119.1% | 255,855 | +63.6% | 0.00% | – |
| Q1 2020 | $383,000 | -48.7% | 156,376 | -1.0% | 0.00% | – |
| Q4 2019 | $746,000 | +45.7% | 157,964 | +32.0% | 0.00% | – |
| Q3 2019 | $512,000 | -34.3% | 119,714 | -10.4% | 0.00% | – |
| Q2 2019 | $779,000 | +81.2% | 133,649 | +19.7% | 0.00% | – |
| Q1 2019 | $430,000 | +109.8% | 111,611 | +1.4% | 0.00% | – |
| Q4 2018 | $205,000 | -43.8% | 110,048 | -3.5% | 0.00% | – |
| Q3 2018 | $365,000 | -59.7% | 114,049 | -61.9% | 0.00% | – |
| Q2 2018 | $905,000 | -8.1% | 299,618 | +19.3% | 0.00% | – |
| Q1 2018 | $985,000 | +19.2% | 251,068 | +25.8% | 0.00% | – |
| Q4 2017 | $826,000 | -38.4% | 199,569 | -8.5% | 0.00% | – |
| Q3 2017 | $1,340,000 | +3.6% | 218,173 | +4.9% | 0.00% | – |
| Q2 2017 | $1,293,000 | +2.3% | 207,982 | +4.3% | 0.00% | – |
| Q1 2017 | $1,264,000 | +25.1% | 199,406 | +5.5% | 0.00% | – |
| Q4 2016 | $1,010,000 | +14.4% | 188,982 | +20.4% | 0.00% | – |
| Q3 2016 | $883,000 | +4.0% | 156,929 | +1.4% | 0.00% | – |
| Q2 2016 | $849,000 | -15.4% | 154,770 | +14.6% | 0.00% | – |
| Q1 2016 | $1,003,000 | -28.5% | 135,016 | -19.9% | 0.00% | -100.0% |
| Q4 2015 | $1,402,000 | +9.2% | 168,616 | +18.4% | 0.00% | 0.0% |
| Q3 2015 | $1,284,000 | -6.3% | 142,383 | +24.7% | 0.00% | 0.0% |
| Q2 2015 | $1,371,000 | +2.0% | 114,172 | -8.5% | 0.00% | – |
| Q1 2015 | $1,344,000 | +975.2% | 124,780 | +406.9% | 0.00% | – |
| Q4 2014 | $125,000 | +108.3% | 24,615 | +9.0% | 0.00% | – |
| Q3 2014 | $60,000 | -53.1% | 22,584 | -29.4% | 0.00% | – |
| Q2 2014 | $128,000 | +40.7% | 31,986 | +60.9% | 0.00% | – |
| Q1 2014 | $91,000 | +264.0% | 19,880 | +239.8% | 0.00% | – |
| Q4 2013 | $25,000 | +8.7% | 5,850 | 0.0% | 0.00% | – |
| Q3 2013 | $23,000 | -46.5% | 5,850 | -71.1% | 0.00% | – |
| Q2 2013 | $43,000 | – | 20,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |